CN118347920A

CN118347920A - Sample analyzer and sample analysis method

Info

Publication number: CN118347920A
Application number: CN202410345366.6A
Authority: CN
Inventors: 易秋实; 叶燚; 李学荣
Original assignee: Shenzhen Mindray Bio Medical Electronics Co Ltd
Current assignee: Shenzhen Mindray Bio Medical Electronics Co Ltd
Filing date: 2020-05-14
Publication date: 2024-07-16

Abstract

The embodiment of the application discloses a sample analysis method and a sample analyzer, which are used for mixing a sample to be tested with a processing reagent to react to obtain a sample liquid to be tested; passing particles in a sample liquid to be measured through a detection area of an optical detection system one by one and irradiating the particles passing through the detection area with light having a first wavelength and light having a second wavelength shorter than the first wavelength; acquiring first optical information generated after particles in a sample liquid to be detected are irradiated by light with a first wavelength and second optical information generated after particles in the sample liquid to be detected are irradiated by light with a second wavelength; analyzing cells to be detected in the sample liquid to be detected according to at least one of scattered light intensity information in the first optical information and the second optical information and first fluorescence intensity information in the first optical information; and identifying whether a pathogen to be detected exists in the sample liquid to be detected according to at least one of the first optical information and the second optical information and the scattered light intensity information in the second optical information.

Description

Sample analyzer and sample analysis method

The application relates to a patent application with the application number 202010408611.5 of being the 14 th day of the year 2020 and the application name of 'sample analyzer and sample analysis method'.

Technical Field

The application relates to the field of medical detection, in particular to the field of in-vitro diagnosis, and relates to a sample analyzer and a sample analysis method.

Background

The flow cytometry is used as a medical detection instrument for automatically detecting and analyzing blood cells (such as five-class white blood cells, nucleated red blood cells and reticulocyte identification) in body fluid (such as blood, urine, cerebrospinal fluid and the like), is widely applied to clinical detection in hospitals at present, and is a mature and excellent-performance detection instrument. Currently, the light source used in the commonly used flow cytometers is mainly a red laser light source. Flow cytometry can also be used for detection of pathogens in body fluids. For a hematology analyzer that uses a red laser as the light source, the smallest detection particle is a platelet, which has an average diameter of about 2.7 micrometers (μm), and a minimum diameter of greater than about 1 μm. However, the diameter of pathogens is typically below 1 μm, resulting in failure of existing flow cytometers employing red laser light sources to identify pathogens.

In order to realize detection of particles with smaller diameters, such as pathogens, using flow cytometers, some flow cytometers manufacturers have developed flow cytometers that use short wavelength lasers, such as ultraviolet light or violet light, as light sources. However, when the flow cytometry with the short wavelength light source is used for detecting the blood cells, on one hand, since the short wavelength light source has a strong amplifying effect on the tiny particles, the signals of fragments generated by the dissolution of the red blood cells are amplified during the detection of the blood cells, and the detection of the blood cells is interfered; on the other hand, short wavelength light sources have difficulty exciting fluorescent dyes currently used for staining blood cells.

Thus, it is currently difficult to achieve detection of blood cells and pathogens in the same detection channel by existing cell analyzers.

Disclosure of Invention

In view of this, the embodiment of the application is expected to provide a sample analyzer and a sample analysis method, which realize the simultaneous detection of blood cells and pathogens in the same detection channel and improve the screening capability of the flow cytometry analyzer.

A first aspect of the present application provides a sample analyzer comprising:

the sampling part is used for acquiring a sample to be detected and conveying the sample to be detected to the reaction part;

a reagent supply section for storing a reagent and supplying the reagent to the reaction section as needed; wherein the reagent at least comprises a hemolysis agent for treating erythrocytes or cell membranes of erythrocytes in the sample to be detected, a first fluorescent dye for staining cells to be detected in the sample to be detected, and a second fluorescent dye for staining pathogens to be detected in the sample to be detected;

a reaction part, which comprises a mixing chamber for mixing and reacting the sample to be tested and the reagent to form a sample liquid to be tested;

An optical detection system including a first light source for irradiating particles flowing in the flow chamber with light having a first wavelength so as to generate first optical information, a second light source for irradiating particles flowing in the flow chamber with light having a second wavelength shorter than the first wavelength so as to generate second optical information, a first scatter detector for collecting first scattered light intensity information in the first optical information, a first fluorescence detector for collecting second scattered light intensity information in the second optical information, and a second fluorescence detector for collecting first fluorescent light intensity information in the first optical information;

a transporting device for transporting the sample liquid to be measured after the reagent treatment in the reaction part into a flow chamber of the optical detection system;

A processor configured to acquire the first scattered light intensity information, the second scattered light intensity information, the first fluorescence intensity information, and the second fluorescence intensity information from the optical detection system; analyzing cells to be detected in the sample liquid to be detected according to at least one of the first scattered light intensity information and the second scattered light intensity information and the first fluorescence intensity information; and identifying whether a pathogen to be detected exists in the sample liquid to be detected according to the first scattered light intensity information, at least one of the first fluorescence intensity information and the second scattered light intensity information.

The second aspect of the present application also provides a sample analyzer comprising:

a reagent supply section for storing a reagent and supplying the reagent to the reaction section as needed; wherein the reagent at least comprises a hemolyzing agent for treating erythrocytes or cell membranes of erythrocytes in the sample to be detected and a fluorescent dye for staining the cells to be detected in the sample to be detected;

An optical detection system including a first light source for irradiating particles flowing in a flow chamber with light having a first wavelength so as to generate first optical information, a second light source for irradiating particles flowing in the flow chamber with light having a second wavelength shorter than the first wavelength so as to generate second optical information, a first scatter detector for collecting first scattered light intensity information in the first optical information, a second scatter detector for collecting second scattered light intensity information in the second optical information, and a fluorescence detector for collecting first fluorescence intensity information in the first optical information;

a processor configured to acquire the first scattered light intensity information, the second scattered light intensity information, and the first fluorescence intensity information from the optical detection system; analyzing cells to be detected in the sample liquid to be detected according to at least one of the first scattered light intensity information and the second scattered light intensity information and the first fluorescence intensity information; and identifying whether a pathogen to be detected exists in the sample liquid to be detected according to at least the second scattered light intensity information.

The third aspect of the embodiment of the application also provides a sample analysis method, which comprises the following steps:

Mixing a sample to be tested with a reagent, and reacting to obtain a sample solution to be tested; wherein the reagent at least comprises a hemolysis agent for treating erythrocytes or cell membranes of erythrocytes in the sample to be detected, a first fluorescent dye for staining cells in the sample to be detected, and a second fluorescent dye for staining pathogens to be detected in the sample to be detected;

Passing particles in the sample liquid to be tested one by one through a detection zone of an optical detection system and irradiating the particles passing through the detection zone with light having a first wavelength and light having a second wavelength shorter than the first wavelength;

acquiring first optical information generated after particles in the sample liquid to be tested are irradiated by light with a first wavelength and second optical information generated after particles in the sample liquid to be tested are irradiated by light with a second wavelength;

analyzing cells to be detected in the sample liquid to be detected according to at least one of scattered light intensity information in the first optical information and the second optical information and first fluorescence intensity information in the first optical information;

and identifying whether a pathogen to be detected exists in the sample liquid to be detected according to at least one piece of other light intensity information in the first optical information and the second optical information and the scattered light intensity information in the second optical information.

The fourth aspect of the embodiment of the application also provides a sample analysis method, which comprises the following steps:

Mixing a sample to be tested with a reagent, and reacting to obtain a sample solution to be tested; wherein the reagent at least comprises a hemolyzing agent for treating erythrocytes or cell membranes of erythrocytes in the sample to be detected and a fluorescent dye for staining the cells to be detected in the sample to be detected;

and identifying whether a pathogen to be detected exists in the sample liquid to be detected according to at least the second scattered light intensity information.

According to the sample analyzer and the sample analysis method provided by the embodiment of the application, after a sample to be detected and a reagent are mixed and react to obtain a sample liquid to be detected, particles in the sample liquid to be detected pass through a detection area of an optical detection system one by one and simultaneously irradiate the particles passing through the detection area by adopting two types of light with different wavelengths, first optical information and second optical information generated after the particles are irradiated by the light with the two different wavelengths are collected, and cells to be detected in the sample liquid to be detected are analyzed and whether pathogens to be detected exist in the sample liquid to be detected are identified according to different combinations of all light intensity information in the first optical information and/or all light intensity information in the second optical information. Or, two kinds of light with different wavelengths are adopted to irradiate the same sample liquid to be detected at the same time, so that different light information generated after the sample liquid to be detected is irradiated by the light with different wavelengths is obtained, and the simultaneous detection of blood cells and pathogens is realized. Therefore, the problem that blood cells and pathogens in a sample cannot be detected simultaneously through the same sample liquid to be detected at present is solved, the screening capability of the flow type sample analyzer is improved, blood abnormality can be found in early stage of pathogen infection of patients, and precious time is striven for subsequent monitoring and treatment.

Drawings

Fig. 1 is a schematic structural diagram of a sample analyzer according to an embodiment of the present application;

fig. 2 is a schematic structural diagram of an optical detection system according to an embodiment of the present application;

fig. 3 is a schematic structural diagram of a light source of an optical detection system according to an embodiment of the present application;

FIG. 4 is a schematic diagram of a forward scattered light collecting device with a first forward scattered light detector according to an embodiment of the present application;

FIG. 5 is a schematic diagram of a forward scattered light collecting device with a second forward scattered light detector according to an embodiment of the present application;

FIG. 6 is a schematic diagram of a forward scattered light collecting device with a first forward scattered light detector and a second forward scattered light detector according to an embodiment of the present application;

FIG. 7 is a schematic diagram of a fluorescence collection device with two fluorescence detectors according to an embodiment of the present application;

FIG. 8 is a schematic flow chart of a sample analysis method according to an embodiment of the present application;

FIG. 9 is a two-dimensional scatter plot of side scatter light intensity versus fluorescence intensity for analysis of white blood cells provided by an embodiment of the present application;

FIG. 10 is a two-dimensional scatter plot of forward scattered light intensity versus fluorescence intensity for identifying detected pathogens provided by an embodiment of the present application;

FIG. 11 is a flow chart of another sample analysis method according to an embodiment of the present application;

fig. 12 is a schematic structural diagram of a sample analyzer according to an embodiment of the present application.

Detailed Description

For the purpose of making the objects, technical solutions and advantages of the embodiments of the present application more apparent, the technical solutions of the embodiments of the present application will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present application, and it is apparent that the described embodiments are only some embodiments of the present application, not all embodiments of the present application. All other embodiments, based on the embodiments of the application, which are apparent to those of ordinary skill in the art without inventive faculty, are intended to be within the scope of the application.

Throughout the specification, unless specifically indicated otherwise, the terms used herein should be understood as meaning as commonly used in the art. Accordingly, unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this application belongs. In case of conflict, the present specification will control.

It should be noted that, in the embodiments of the present application, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a method or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such method or apparatus. Without further limitation, an element defined by the phrase "comprising one … …" does not exclude the presence of other related elements (e.g., a step in a method or a unit in an apparatus, where the unit may be a part of a circuit, a part of a processor, a part of a program or software, etc.) in a method or apparatus comprising the element.

It should be noted that, the term "first\second\third" related to the embodiment of the present application is merely to distinguish similar objects, and does not represent a specific order for the objects, it is to be understood that "first\second\third" may interchange a specific order or sequence where allowed. It is to be understood that the "first\second\third" distinguishing aspects may be interchanged where appropriate to enable embodiments of the application described herein to be implemented in sequences other than those illustrated or described.

A first aspect of the application provides a sample analyzer 100, in particular a blood sample analyzer. Referring to fig. 1, the sample analyzer 100 includes a sampling part 110, a sample preparation device 120, an optical detection system 130, a transport device (not shown), and a processor 150.

The sampling part 110 is used for acquiring a sample to be measured and delivering the sample to be measured to the sample preparation device 120. In an embodiment, the sampling part 110 may have a pipette (e.g., a sampling needle) with a pipette nozzle and have a driving part for driving the pipette to quantitatively aspirate the sample to be measured through the pipette nozzle, e.g., the sampling needle is moved into the sample container to aspirate the sample to be measured by the driving of the driving part.

The sample preparation device 120 has a reaction section and a reagent supply section (not shown). The reaction part is for receiving the sample to be measured sucked by the sampling part 110. The reagent supply section is configured to store a reagent and supply the reagent to the reaction section as needed, so that the sample to be measured sucked by the sampling section 110 and the processing reagent supplied from the reagent supply section are mixed and reacted in the mixing chamber of the reaction section to prepare a sample liquid to be measured. The treatment reagent may include a hemolyzing agent for treating erythrocytes or cell membranes of erythrocytes in the sample to be measured, a first fluorescent dye for staining cells to be measured in the sample to be measured, and a second fluorescent dye for staining pathogens to be measured in the sample to be measured.

The optical detection system 130 includes a first light source for irradiating particles flowing in the flow cell with light having a first wavelength so as to generate first optical information, a second light source for irradiating particles flowing in the flow cell with light having a second wavelength shorter than the first wavelength so as to generate second optical information, a flow cell, a first scatter detector, a second scatter detector, a first fluorescence detector, and a second fluorescence detector in which particles in a sample liquid to be measured can flow. That is, the first light source and the second light source simultaneously irradiate the particles flowing in the flow chamber so that the particles generate the first optical information and the second optical information. The first scattered light detector is used for collecting first scattered light intensity information in the first optical information, the second scattered light detector is used for collecting second scattered light intensity information in the second optical information, the first fluorescence detector is used for collecting first fluorescence intensity information in the first optical information, and the second fluorescence detector is used for collecting second fluorescence intensity information in the second optical information.

The conveying device is used for conveying the sample liquid to be detected after the reagent treatment in the reaction part into a flow chamber of the optical detection system. The delivery device may, for example, comprise a conduit for delivering the liquid and a power source for driving the liquid to flow in the conduit.

The processor 150 is configured to: acquiring first scattered light intensity information, second scattered light intensity information, first fluorescence intensity information, and second fluorescence intensity information from the optical detection system 130; analyzing cells to be detected in the sample liquid to be detected according to at least one of the first scattered light intensity information and the second scattered light intensity information and the first fluorescence intensity information; and identifying whether a pathogen to be detected exists in the sample liquid to be detected according to at least one of the first scattered light intensity information, the first fluorescence intensity information and the second scattered light intensity information. For example, the cells to be detected may be white blood cells or red blood cells or platelets or reticulocytes, and the pathogen to be detected may be a parasite.

Therefore, after the sample to be detected and the reagent are mixed and reacted to obtain the sample liquid to be detected, particles in the sample liquid to be detected pass through a detection area of an optical detection system one by one and adopt two types of light with different wavelengths to irradiate the particles passing through the detection area at the same time, first optical information and second optical information generated after the particles are irradiated by the light with two different wavelengths are collected, cells to be detected in the sample liquid to be detected and whether pathogens to be detected exist in the sample liquid to be detected are identified according to different combinations of the light intensity information in the first optical information and/or the light intensity information in the second optical information, the problem that the blood cells and the pathogens in the sample cannot be detected simultaneously by the same sample liquid to be detected at present is solved, the additional blood sample is not consumed to detect the pathogens, and the screening capability of the flow sample analyzer is improved.

In some embodiments, the sample analyzer 100 further includes a display device 140 for displaying the detection result. For example, the display device 140 is configured as a user interface.

In some embodiments, the sample analyzer 100 further includes a first housing 160 and a second housing 170. The optical detection system 130 and the processor 150 are disposed inside the second housing 170, and disposed on two sides of the second housing 170, respectively. The sample preparation device 120 is disposed inside the first housing 160. The display device 140 is disposed on an outer surface of the first casing 160.

In some embodiments, the sample analyzer 100 may further include a photoelectric converter (not shown) electrically connected to the optical detection system 130 for converting the optical signal captured by the optical detection system 130 into an electrical pulse signal for analysis.

In other embodiments of the application, the second scattered light detector comprises a second forward scattered light detector for collecting second forward scattered light intensity information in the second optical information. Accordingly, the processor is specifically configured to identify whether a pathogen to be detected is present in the test sample fluid by: and identifying whether a pathogen to be detected exists in the sample liquid to be detected according to at least one of the first scattered light intensity information, the first fluorescence intensity information and the second forward scattered light intensity information. The second forward scattered light intensity information facilitates pathogen recognition. Preferably, the processor is specifically configured to effect the identification of the presence or absence of a pathogen to be detected in the test sample liquid by: and identifying whether a pathogen to be detected exists in the sample liquid to be detected according to at least the second fluorescence intensity information and the second forward scattering light intensity information. This allows a better recognition of the pathogen.

Further, the second scatter detector includes a second side scatter detector for collecting second side scatter light intensity information in the second optical information in addition to the second forward scatter detector. Accordingly, the processor is specifically configured to identify whether a pathogen to be detected is present in the test sample fluid by: and identifying whether a pathogen to be detected exists in the sample liquid to be detected according to the second forward scattering light intensity information, the second side scattering light intensity information and the second fluorescence intensity information.

In other embodiments of the application, the first scatter detector comprises at least one of a first forward scatter detector for collecting first forward scatter light intensity information in the first optical information and a first side scatter detector for collecting first side scatter light intensity information in the first optical information. Accordingly, the processor is specifically configured to perform an analysis of cells to be detected in a test sample solution by: and analyzing the cells to be detected in the sample liquid to be detected according to the first fluorescence intensity information and at least one of the first forward scattering light intensity information and the first side scattering light intensity information. In one embodiment, the first scattered light detector comprises a first side scattered light detector for collecting first side scattered light intensity information in the first optical information, and the processor is correspondingly configured for analyzing cells to be detected in the sample liquid to be detected according to the first side scattered light intensity information and the first fluorescence intensity information. In another embodiment, the first scatter detector comprises a first forward scatter detector for collecting first forward scatter light intensity information in the first optical information and a first side scatter detector for collecting first side scatter light intensity information in the first optical information, and the processor is correspondingly configured for analyzing the cells to be detected in the sample liquid to be detected based on the first forward scatter light intensity information, the first side scatter light intensity information and the first fluorescence intensity information.

In other embodiments of the application, the second scattered light detector comprises a second side scatter detector for collecting second side scatter light intensity information in the second optical information. Accordingly, the processor is specifically configured to perform an analysis of cells to be detected in a test sample solution by: and analyzing the cells to be detected in the sample liquid to be detected according to the second side scattering light intensity information and the first fluorescence intensity information.

In other embodiments of the present application, the cell to be detected may be a leukocyte, and the processor may be specifically configured to implement the following steps: according to at least one of the first scattered light intensity information and the second scattered light intensity information and the first fluorescence intensity information, classifying cells to be detected in the sample liquid to be detected into at least monocyte subpopulations, lymphocyte subpopulations, neutrophil subpopulations and eosinophil subpopulations, and optionally identifying whether the naive granulocytes exist in the sample liquid to be detected. Preferably, the processor is specifically configured to classify the cells to be detected in the test sample liquid into at least a monocyte subpopulation, a lymphocyte subpopulation, a neutrophil subpopulation, an eosinophil subpopulation based on the first side scatter light intensity information and the first fluorescence intensity information (optionally also based on the first forward scatter light intensity information). In this case, the hemolysis agent is an agent for lysing erythrocytes, and the first fluorescent dye is a dye solution capable of staining leukocytes, such as DIFF channel dye solution in the commercially available merrill haemocytometer. That is, the embodiment of the application can realize the white blood cell classification and pathogen identification in the existing DIFF channel through the design of the double light sources and the double dyes, and does not need to open a new detection channel for pathogen detection, namely does not need to consume extra blood samples.

In other embodiments of the present application, the processor may be specifically configured to identify white blood cells or basophils in the sample solution to be tested, and optionally identify whether nucleated red blood cells exist in the sample solution to be tested, according to at least one of the first scattered light intensity information and the second scattered light intensity information and the first fluorescence intensity information. In this case, the hemolysis agent is an agent for lysing erythrocytes, and the first fluorescent dye is a dye solution capable of staining nucleated erythrocytes, such as the WNB channel dye solution in the commercially available michaelines. That is, the embodiment of the application can realize the white blood cell count/basophil identification/nucleated red blood cell identification and pathogen identification in the existing WNB channel through the design of the double light sources and the double dyes, and does not need to open a new detection channel for pathogen detection.

In other embodiments of the present application, the processor may be specifically configured to identify at least one of reticulocytes, platelets, and mature red blood cells in the test sample solution based on the first fluorescence intensity information and at least one of the first scattered light intensity information and the second scattered light intensity information. In this case, the hemolytic agent is an agent for slightly destroying the cell membrane of the red blood cells and maintaining the morphology of the red blood cells, and is used for promoting the staining of the red blood cells by the dye. The first fluorescent dye is a dye solution capable of staining red blood cells and/or platelets.

In other embodiments of the application, the processor is configured to perform the following steps in identifying whether a pathogen to be detected is present in the test sample fluid: counting the number of pathogens to be detected according to at least one of the first scattered light intensity information, the first fluorescence intensity information and the second scattered light intensity information, and when the number is larger than a preset threshold value, the pathogens to be detected exist in the sample liquid to be detected.

In other embodiments of the present application, the processor is configured to generate a first scatter diagram according to at least one of the first scattered light intensity information and the second scattered light intensity information and the first fluorescence intensity information when analyzing the cells to be detected in the sample liquid to be detected, and analyze the cells to be detected in the sample liquid to be detected according to the first scatter diagram; and

The processor is configured to generate a second scatter diagram according to the second scattered light intensity information and at least one of the first scattered light intensity information and the second fluorescence intensity information when identifying whether the pathogen to be detected exists in the sample liquid to be detected, and identify whether the pathogen to be detected exists in the sample liquid to be detected according to the second scatter diagram.

In other embodiments of the application, the processor is further configured to perform the steps of: and outputting an alarm prompt when the pathogen to be detected exists in the sample liquid to be detected.

In other embodiments of the present application, the first wavelength is greater than 600nm and the second wavelength is less than or equal to 600nm. Preferably, the first light source is configured to emit red light and the second light source is configured to emit green or blue light. For example, the first wavelength is 635nm and the second wavelength is 375nm, 405nm, 450nm, 488nm or 520nm.

The second aspect of the present application also provides a sample analyzer comprising: the device comprises a sampling part, a reagent supply part, a reaction part, an optical detection system, a conveying device and a processor; wherein:

the sampling part is used for acquiring a sample to be tested and conveying the sample to be tested to the reaction part;

A reagent supply section for storing the reagent and supplying the reagent to the reaction section as needed; the reagent at least comprises a hemolytic agent for treating erythrocytes or cell membranes of erythrocytes in the sample to be detected and a first fluorescent dye for staining the cells in the sample to be detected;

the reaction part comprises a mixing chamber for mixing and reacting a sample to be tested with a reagent to form a sample liquid to be tested;

an optical detection system including a first light source for irradiating particles flowing in a flow cell with light having a first wavelength so as to generate first optical information, a second light source for irradiating particles flowing in the flow cell with light having a second wavelength shorter than the first wavelength so as to generate second optical information, a flow cell, a first scatter detector for collecting the first scattered light intensity information in the first optical information, a second scatter detector for collecting the second scattered light intensity information in the second optical information, and a fluorescence detector (first fluorescence detector) for collecting the first fluorescence intensity information in the first optical information;

A conveying device for conveying the sample liquid to be detected after the reagent treatment in the reaction part into a flow chamber of the optical detection system;

A processor configured to obtain first scattered light intensity information, second scattered light intensity information, and first fluorescence intensity information from the optical detection system; analyzing cells to be detected in the sample liquid to be detected according to at least one of the first scattered light intensity information and the second scattered light intensity information and the first fluorescence intensity information; and identifying whether a pathogen to be detected exists in the sample liquid to be detected according to at least the second scattered light intensity information.

Therefore, the method can realize the simultaneous detection of blood cells and pathogens, solves the problem that the blood cells and pathogens in a sample cannot be detected simultaneously through the same sample liquid to be detected at present, and improves the screening capability of the flow type sample analyzer.

In other embodiments of the application, the second scattered-light detector comprises a second forward scattered-light detector for collecting second forward scattered-light intensity information in the second optical information and a second side scattered-light detector for collecting second side scattered-light intensity information in the second optical information. Accordingly, the processor is specifically configured to identify whether a pathogen to be detected is present in the test sample fluid by: and identifying whether a pathogen to be detected exists in the sample liquid to be detected according to the second forward scattering light intensity information and the second side scattering light intensity information.

In other embodiments of the present application, the first wavelength is greater than 600nm and the second wavelength is less than or equal to 600nm.

In other embodiments of the present application, the first wavelength is 635nm; and/or the second wavelength is 375nm, 405nm, 450nm, 488nm or 520nm.

Further embodiments of the sample analyzer according to the second aspect of the present application may be referred to the description of the respective embodiments of the sample analyzer according to the first aspect of the present application, and will not be repeated here.

An optical detection system according to an embodiment of the present application, which may be used in the sample analyzer according to the first and second aspects of the present application, is described in detail below with reference to fig. 2 to 7.

In one embodiment, as shown in fig. 2, the optical detection system includes a first light source a, a second light source B, an optical path combiner C, a flow cell D, a forward scattered light collecting device E for collecting forward scattered light, a first beam splitter F, a side scattered light collecting device G for collecting side scattered light, and a fluorescence collecting device H for collecting fluorescence.

The first light source a may be configured as a first laser capable of emitting a first laser beam having a first wavelength, and the second light source B may be configured as a second laser capable of emitting a second laser beam having a second wavelength different from the first wavelength, the first laser beam emitted by the first laser and the second laser beam emitted by the second laser being optically coupled by the optical path combiner C so as to couple the two optical paths into one optical path, to obtain a target laser beam, and to irradiate particles flowing in the flow chamber D so that the particles generate the first optical information and the second optical information.

As shown in fig. 3, a first light beam emitted by a first light source a is processed by a first pre-light processing component I1, then is incident on an optical path beam combiner C and is transmitted through the optical path beam combiner C, and a second light beam emitted by a second light source B is processed by a second pre-light processing component I2, then is incident on the optical path beam combiner C and is reflected by the optical path beam combiner C, so that the first light beam and the second light beam are coupled in an optical path to obtain a target laser beam, and are focused at the center of a flow chamber D in the flow direction of particles, and the particles flowing in the flow chamber D are irradiated. Here, the first and second front light processing components I1 and I2 may, for example, each include a focusing lens and optionally a beam collimating lens.

The forward scattered light collecting means E may be arranged in line with the flow chamber D in the propagation direction of the target laser beam and downstream of the flow chamber D. On one side of the flow chamber D, the first beam splitter F is arranged at an angle, for example 45 deg., to said straight line. A part of the lateral light emitted by the particles in the flow cell D is transmitted through the first beam splitter F and is captured by the fluorescence collection device H arranged behind the first beam splitter F at an angle, e.g. 45 °, to the first beam splitter F, while another part of the lateral light is reflected by the first beam splitter F and is captured by the lateral scattered light collection device G arranged in front of the first beam splitter F at an angle, e.g. 45 °.

In an embodiment of the present application, as shown in fig. 4, the forward scattered light collecting device E may include a first converging lens J1, a first aperture stop K1, and a first forward scattered light detector E1 for collecting first forward scattered light intensity information in first optical information generated after the first light source irradiates particles flowing in the flow chamber. Specifically, the first forward scattered light generated after the particles flowing in the flow chamber D are irradiated with the light of the first wavelength is focused at the first aperture stop K1 by the first condensing lens J1, and then is incident into the first forward scattered light detector E1. At this time, the first aperture stop K1 is designed such that the first aperture stop K1 blocks most of the second forward scattered light generated after the particles flowing in the flow chamber D are irradiated with the light of the second wavelength and the first forward scattered light deviated from the focal point. Further, since the first aperture stop K1 may not be capable of completely blocking all the second forward scattered light, a first filter L1 may be further disposed between the first aperture stop K1 and the first forward scattered light detector E1, for filtering out the second forward scattered light that continues to propagate forward after passing through the first aperture stop K1. It should be noted that the aperture of the aperture diaphragm is generally between 0.2mm and 2 mm; the filter is generally a common filter in the industry, as long as the filter can transmit the first forward scattered light and attenuate the second forward scattered light, and the embodiment of the application is not limited in particular. The dashed line D1 in the flow chamber D is the particle flow path.

In an embodiment of the present application, as shown in fig. 5, the forward scattered light collecting device E may include a first converging lens J1, a second small aperture stop K2 and a second forward scattered light detector E2 for collecting second forward scattered light intensity information in second optical information generated after the second light source irradiates the particles flowing in the flow chamber. Similarly to fig. 4, the second forward scattered light generated after the particles flowing in the flow chamber D are irradiated with the light of the second wavelength is focused at the second aperture stop K2 by the first condensing lens J1, and is then incident into the second forward scattered light detector E2. At this time, the second aperture stop K2 is designed such that the second aperture stop K2 blocks most of the first forward scattered light generated after the particles flowing in the flow chamber D are irradiated with the light of the first wavelength and the second forward scattered light deviated from the focal point. Further, a second filter L2 is disposed between the second aperture stop K2 and the second forward scattered light detector E2, for filtering the first forward scattered light that continues to propagate forward after passing through the second aperture stop K2.

In an embodiment of the present application, as shown in fig. 6, the forward scattered light collecting device E may include a first converging lens J1, a first aperture stop K1, a second aperture stop K2, a first forward scattered light detector E1 for collecting first forward scattered light intensity information in first optical information generated after the first light source irradiates the particles flowing in the flow chamber, and a second forward scattered light detector E2 for collecting second forward scattered light intensity information in second optical information generated after the second light source irradiates the particles flowing in the flow chamber. After the forward scattered light emitted by the particles in the flow cell D passes through the first converging lens J1, a part passes through the second beam splitter M and is captured by the first forward scattered light detector E1 arranged at an angle, e.g. 45 °, to the second beam splitter M behind the second beam splitter M, while another part of the forward scattered light is reflected by the second beam splitter M and is captured by the second forward scattered light detector E2 arranged at an angle, e.g. 45 °, to the second beam splitter M in front of the second beam splitter M. The first aperture stop K1 and the first filter L1 arranged between the second beam splitter M and the first forward scatter detector E1 are designed such that substantially only first forward scatter light enters the first forward scatter detector E1. Similarly, the second aperture stop K2 and the second filter L2, which are arranged between the second beam splitter M and the second forward scatter detector E2, are designed such that substantially only the second forward scatter light enters the second forward scatter detector E2.

In an embodiment of the present application, the side scatter light collecting means G may comprise at least one of a first side scatter light detector and a second side scatter light detector. The first side scatter detector is used for collecting first side scatter light intensity information in first optical information generated after the first light source irradiates particles flowing in the flow chamber, and the second side scatter detector is used for collecting second side scatter light intensity information in second optical information generated after the second light source irradiates particles flowing in the flow chamber. It should be noted that, the specific structural design of the side-scattered light collecting device G may refer to the description of the forward-scattered light collecting device E in fig. 4 to 6, wherein the functions of the corresponding components are changed accordingly, and detailed descriptions thereof are omitted herein.

In an embodiment of the application, the fluorescence collection device H may comprise a first fluorescence detector and optionally a second fluorescence detector. The first fluorescence detector is used for collecting first fluorescence intensity information in first optical information generated after the first light source irradiates the particles flowing in the flow chamber, and the second fluorescence detector is used for collecting second fluorescence intensity information in second optical information generated after the second light source irradiates the particles flowing in the flow chamber. It should be noted that, the specific structural design of the fluorescence collection device H may refer to the description of the forward scattered light collection device E in fig. 4 and 6. As shown in fig. 7, taking an example in which the fluorescence collection device H includes a first fluorescence detector H1 and a second fluorescence detector H2, after the lateral light emitted by the particles in the flow chamber D passes through the second condensing lens J2, a part of the lateral light (fluorescence) is transmitted through the first beam splitter F and captured by the fluorescence collection device H disposed at an angle, for example, 45 ° to the first beam splitter F, and another part of the lateral light (lateral scattered light) is reflected by the first beam splitter F and captured by the lateral scattered light collection device G disposed at an angle, for example, 45 ° to the first beam splitter F, in front of the first beam splitter F. Wherein a part of the lateral light transmitted through the first beam splitter F is transmitted through the third beam splitter N and is captured by the first fluorescence detector H1 arranged behind the third beam splitter N at an angle, e.g. 45 °, to the third beam splitter N, while another part of the lateral light is reflected by the third beam splitter N and is captured by the second fluorescence detector H2 arranged in front of the third beam splitter N at an angle, e.g. 45 °. Here, the third aperture stop K3 and the third filter L3 arranged between the third light splitter N and the first fluorescence detector H1 are designed such that substantially only the first fluorescence enters the first fluorescence detector H1. Similarly, the fourth aperture stop K4 and the fourth filter L4 arranged between the third light splitter N and the second fluorescence detector H2 are designed such that substantially only the second fluorescence enters the second fluorescence detector H2.

In an embodiment of the present application, the first forward scatter detector, the second forward scatter detector, the first side scatter detector, the second side scatter detector, the first fluorescence detector, the second fluorescence detector, and the like may be photodiodes, photomultipliers, and the like. The first, second and third beamsplitters may be dichroic mirrors.

The sample analysis method according to the present application will be described in detail with reference to the foregoing sample analyzer and the corresponding fig. 8 to 11. The sample analysis method may be implemented by a processor of the sample analyzer provided by the embodiment of the present application.

A third aspect of the present application provides a sample analysis method applicable to the sample analyzer provided in the first aspect of the present application, as shown with reference to fig. 8, the method comprising the steps of:

Step 201, mixing a sample to be tested with a processing reagent, and reacting to obtain a sample solution to be tested, wherein the processing reagent at least comprises a hemolysis agent for processing erythrocytes or cell membranes of erythrocytes in the sample to be tested, a first fluorescent dye for dyeing cells in the sample to be tested, and a second fluorescent dye for dyeing pathogens to be tested in the sample to be tested.

In the embodiment of the present application, the sample to be tested generally refers to a blood sample to be tested, and in some application scenarios, the sample to be tested may also be a body fluid including blood cells. The hemolyzing agent may be an agent for lysing erythrocytes in the sample to be tested, or may be an agent for slightly disrupting the cell membrane of erythrocytes and maintaining the morphology of erythrocytes so as to promote staining of erythrocytes by the first fluorescent dye. In some application scenarios, the processing reagent may include a diluent for diluting the sample to be tested in addition to the hemolysis agent, the first fluorescent dye, and the second fluorescent dye.

The first fluorescent dye may comprise one or more dyes for staining blood cells and the second dye may also comprise one or more dyes that stain the pathogen to be detected. Illustratively, the first fluorescent dye may be, for example, a DIFF channel dye solution and/or a WNB channel dye solution in commercially available michaelines, and the second fluorescent dye may be a dye that stains at least one of a nucleic acid, a protein, a cell membrane, an organelle, and the like of a pathogen. The first fluorescent dye and the second fluorescent dye may be packaged separately or may be mixed in the same reagent bottle or reagent bag, for example.

Step 202, particles in a sample liquid to be measured are made to pass through a detection area of an optical detection system one by one, and the particles passing through the detection area are irradiated with light having a first wavelength and light having a second wavelength shorter than the first wavelength.

In the embodiment of the present application, the particles in the sample liquid to be measured include various types of blood cells in blood, such as erythrocytes, leukocytes, platelets, etc., and may include pathogens, etc.

Illustratively, the light of the first wavelength and the light of the second wavelength are coupled into a beam and focused at a detection zone of the optical detection system. The detection zone of an optical detection system is generally referred to as a flow cell in the optical detection system.

In the embodiment of the application, the first wavelength may be greater than 600nm, and the second wavelength may be less than or equal to 600nm. Further, the first wavelength may be 635nm; and/or the second wavelength may be 375nm, 405nm, 450nm, 488nm or 520nm.

Step 203, obtaining first optical information generated after the particles in the sample liquid to be tested are irradiated by the light with the first wavelength and second optical information generated after the particles in the sample liquid to be tested are irradiated by the light with the second wavelength.

In the embodiment of the application, the first optical information comprises first scattered light intensity information and first fluorescence intensity information generated after the particles in the sample liquid to be detected are irradiated by the light of the first wavelength, and the second optical information comprises second fluorescence intensity information and second scattered light intensity information generated after the particles in the sample liquid to be detected are irradiated by the light of the second wavelength. The first scattered light intensity information may include at least one of first forward scattered light intensity information and first side scattered light intensity information, and the second scattered light intensity information may include at least one of second forward scattered light intensity information and second side scattered light intensity information. Wherein the forward Scattering light signal (FS) reflects the size of the cell particles, the side Scattering light signal (SIDE SCATTERING, SS) reflects the complexity of the internal structure of the cell particles, and the fluorescent signal (FL) reflects the content of substances within the cell particles that can be stained by fluorescent dyes, such as deoxyribonucleic acid (Deoxyribonucleic Acid, DNA) and ribonucleic acid (Ribonucleic Acid, RNA). Furthermore, the optical signal information may include, for example, a pulse width of the optical signal and/or a pulse peak of the optical signal, etc.

And 204, analyzing the cells to be detected in the sample liquid to be detected according to at least one of the scattered light intensity information in the first optical information and the second optical information and the first fluorescence intensity information in the first optical information.

In the embodiment of the application, one or two scattered light intensity information is arbitrarily acquired from the first forward scattered light intensity information and the first side scattered light intensity information included in the first optical information and the second forward scattered light intensity information and the second side scattered light intensity information included in the second optical information, and the cells to be detected in the sample liquid to be detected are analyzed according to the arbitrarily acquired one or two scattered light intensity information and the first fluorescence intensity information in the first optical information. That is, it is necessary to use first fluorescence intensity information and at least one additional scattered light intensity information selected from at least one of first forward scattered light intensity information, first side scattered light intensity information, second forward scattered light intensity information, and second side scattered light intensity information in the first optical information when analyzing the cells to be detected in the sample liquid to be tested.

Step 205, identifying whether a pathogen to be detected exists in the sample liquid to be detected according to at least one of the first optical information and the second optical information and the scattered light intensity information in the second optical information.

In the embodiment of the application, one or two light intensity information is obtained from any one of the first forward scattered light intensity information, the first side scattered light intensity information, the first fluorescence intensity information and the second scattered light intensity information (such as the second side scattered light information) included in the first optical information, and the second fluorescence intensity information, and the pathogen to be detected in the sample liquid to be detected is analyzed according to the one or two light intensity information and the other scattered light intensity information (such as the second forward scattered light information) included in the second optical information.

Therefore, according to the sample analysis method provided by the third aspect of the application, the particles passing through the detection area are simultaneously irradiated by two kinds of light with different wavelengths, the first optical information and the second optical information generated after the particles are irradiated by the two kinds of light with different wavelengths are collected, the cells to be detected in the sample liquid to be detected and whether the pathogens to be detected exist in the sample liquid to be detected are identified according to different combinations of the light intensity information in the first optical information and/or the light intensity information in the second optical information, so that the simultaneous detection of the blood cells and the pathogens is realized, the problem that the blood cells and the pathogens in the sample cannot be detected simultaneously by the same sample liquid to be detected at present is solved, and the screening capability of the flow sample analyzer is improved.

In other embodiments of the present application, the at least one scattered light intensity information comprises first forward scattered light intensity information and/or first side scattered light intensity information in the first optical information; or the at least one scattered light intensity information comprises second side scattered light intensity information in second optical information.

Specifically, in an embodiment, step 204 may be implemented by step a 11:

and a step a11 of analyzing the cells to be detected in the sample liquid to be detected according to at least one of the first forward scattering light intensity information and the first side scattering light intensity information in the first optical information and the first fluorescence intensity information in the first optical information.

In a preferred embodiment, step 204 may be implemented by step a 12:

And a step a12 of analyzing the cells to be detected in the sample liquid to be detected according to the first side scattered light intensity information in the first optical information and the first fluorescence intensity information in the first optical information.

In a preferred embodiment, step 204 may be implemented by step a 13:

and a step a13 of analyzing the cells to be detected in the sample liquid to be detected according to the first forward scattering light intensity information, the first side scattering light intensity information and the first fluorescence intensity information in the first optical information.

In another embodiment, step 204 may be implemented by step a 14:

And a step a14 of analyzing the cells to be detected in the sample liquid to be detected according to the second side scattering light intensity information in the second optical information and the first fluorescence intensity information in the first optical information.

In other embodiments of the present application, the cell to be detected may be a leukocyte, and the corresponding step 204 may be implemented by the following steps: according to at least one of the first scattered light intensity information and the second scattered light intensity information and the first fluorescence intensity information, classifying cells to be detected in the sample liquid to be detected into at least monocyte subpopulation, lymphocyte subpopulation, neutrophil subpopulation and eosinophil subpopulation, and optionally identifying whether the naive granulocytes exist in the sample liquid to be detected. Preferably, the cells to be detected in the sample solution to be detected are classified into at least a monocyte subpopulation, a lymphocyte subpopulation, a neutrophil subpopulation and an eosinophil subpopulation according to the first forward scattered light intensity information, the first side scattered light intensity information and the first fluorescence intensity information. In this case, the hemolysis agent is an agent for lysing erythrocytes, and the first fluorescent dye is a dye solution capable of staining leukocytes, such as DIFF channel dye solution in the commercially available merrill haemocytometer.

In other embodiments of the present application, step 204 may also be implemented by the following steps: and identifying white blood cells or basophils in the sample liquid to be detected according to at least one of the first scattered light intensity information and the second scattered light intensity information and the first fluorescence intensity information, and optionally identifying whether nucleated red blood cells exist in the sample liquid to be detected. In this case, the hemolysis agent is an agent for lysing erythrocytes, and the first fluorescent dye is a dye solution capable of staining nucleated erythrocytes, such as the WNB channel dye solution in the commercially available michaelines.

In other embodiments of the present application, step 204 may also be implemented by the following steps: and identifying at least one of reticulocytes, platelets and mature red blood cells in the sample liquid to be detected according to the first fluorescence intensity information and at least one of the first scattered light intensity information and the second scattered light intensity information. In this case, the hemolytic agent is an agent for slightly destroying the cell membrane of the red blood cells and maintaining the morphology of the red blood cells, and is used for promoting the staining of the red blood cells by the dye. The first fluorescent dye is a dye solution capable of staining red blood cells and/or platelets.

In other embodiments of the present application, step 205 may be implemented by step b 11:

And b11, identifying whether a pathogen to be detected exists in the sample liquid to be detected or not according to at least one piece of additional light intensity information in the first optical information and the second forward scattering light intensity information.

In other embodiments of the present application, step b11 may be implemented by the following steps: and identifying whether a pathogen to be detected exists in the sample liquid to be detected or not according to at least the second fluorescence intensity information and the second forward scattering light intensity information in the second optical information.

In the embodiment of the application, whether the pathogen to be detected exists in the sample liquid to be detected can be identified according to the second fluorescence intensity information and the second forward scattering light intensity information, or whether the pathogen to be detected exists in the sample liquid to be detected can be identified according to the second forward scattering light intensity information, the second side scattering light intensity information and the second fluorescence intensity information. This allows a better recognition of the pathogen.

In other embodiments of the present application, step 205 may be implemented by step b 12:

and b12, identifying whether a pathogen to be detected exists in the sample liquid to be detected or not according to the second side scattering light intensity information and the second forward scattering light intensity information.

In other embodiments of the present application, the "identifying whether the pathogen to be detected exists in the sample liquid to be detected" in step 205 and step b11 may be specifically implemented by the following steps: counting the number of pathogens to be detected according to at least one of the first scattered light intensity information, the first fluorescence intensity information and the second scattered light intensity information; when the number is greater than a preset threshold, the pathogen to be tested is present in the test sample fluid.

In other embodiments of the present application, the "analyzing the cells to be detected in the sample solution to be detected" in step 204, step a11, step a12, step a13, and step a14 may be specifically implemented by the following steps: generating a first scatter diagram according to at least one of the first scattered light intensity information and the second scattered light intensity information and the first fluorescence intensity information, and analyzing cells to be detected in the sample liquid to be detected according to the first scatter diagram.

Correspondingly, the sample analyzer executing the steps 205, b11 and b12 of "identifying whether the pathogen to be detected exists in the sample liquid to be detected" may be specifically implemented by the following steps: generating a second scatter diagram according to the second scattered light intensity information and at least one of the first scattered light intensity information and the second fluorescence intensity information, and identifying whether a pathogen to be detected exists in the sample liquid to be detected according to the second scatter diagram.

In other embodiments of the application, an alarm prompt is output when it is recognized that a pathogen to be detected is present in the test sample fluid. The alarm prompt can be output in a voice mode, can be output in a text and/or picture mode, and can be output in a mode of combining the voice and the text.

Illustratively, the sampling portion of the sample analyzer collects a blood sample and then conveys the blood sample to the reaction portion. A reagent comprising a hemolysis agent, a first fluorescent dye for staining leukocytes, and a second fluorescent dye for staining parasites is simultaneously stored and supplied to the reaction portion. And mixing the blood sample with the reagent at the mixing chamber of the reaction part, and reacting to obtain the sample liquid to be tested. The sample liquid to be measured was flowed in the flow chamber while irradiating particles flowing in the flow chamber with a target laser beam in which a first laser beam having a wavelength of 635nm and a second laser beam having a wavelength of 375nm were coupled. The sample analyzer acquires first optical information and second optical information, wherein the first forward scattering light detector acquires first forward scattering light intensity information corresponding to laser light with a wavelength of 635nm, the second forward scattering light detector acquires second forward scattering light intensity information corresponding to laser light with a wavelength of 375nm, the first fluorescence detector acquires first fluorescence intensity information corresponding to laser light with a wavelength of 635nm, the second fluorescence detector acquires second fluorescence intensity information corresponding to laser light with a wavelength of 375nm, the first side scattering light detector acquires first side scattering light intensity information corresponding to laser light with a wavelength of 635nm, and the second side scattering light detector acquires second side scattering light intensity information corresponding to laser light with a wavelength of 375 nm. The sample analyzer generates a first two-dimensional scatter diagram as shown in fig. 9 according to the first side scattered light intensity information and the first fluorescence intensity information, and performs blood cell classification on the white blood cells according to the first two-dimensional scatter diagram. The abscissa of fig. 9 is the first side scattered light intensity information, and the ordinate is the first forward scattered light intensity information. In fig. 9, the scattered spots in the N1 region are lymphocytes, the scattered spots in the N2 region are monocytes, the scattered spots in the N3 region are neutrophils, the scattered spots in the N4 region are eosinophils, and the scattered spots in the N5 region are hemolysates, i.e., ghosts. The sample analyzer generates a second two-dimensional scatter plot as shown in fig. 10 from the second forward scattered light intensity information and the second fluorescence intensity information, and enables detection of a pathogen to be detected, such as a parasite, from the second two-dimensional scatter plot. The abscissa in fig. 10 is the second forward scattered light intensity information, and the ordinate is the second fluorescence intensity information. Because of the small size of the parasites, the second forward scattered light produced is small, so that the low-value section of the parasites mainly distributed on the abscissa can be determined, and after the parasites are specifically stained, the parasite particles have larger fluorescence intensity and therefore have higher positions than the blood shadow areas on the vertical axis, so that scattered points in the P1 area can be determined as parasites, and scattered points in the P2 area can be determined as blood shadows. Counting the number of scattered points in the P1 area, if the number of scattered points in the P1 area is larger than the preset number, determining that parasites exist, and outputting prompt information of the existence of the parasites by the sample analyzer.

Further, the sample analyzer may further count the number of scattered points in each area corresponding to N1, N2, N3, N4, and N5 shown in fig. 9, and output and display the counted number in each area.

It should be noted that, for further embodiments of the sample analysis method according to the third aspect of the present application, reference may be made to descriptions of various embodiments of the sample analyzer according to the first aspect of the present application, and details thereof are not repeated herein.

The fourth aspect of the present application also provides a sample analysis method applicable to the sample analyzer provided in the second aspect of the present application, as shown with reference to fig. 11, the method comprising the steps of:

step 401, mixing a sample to be tested with a processing reagent, and reacting to obtain a sample solution to be tested.

The treatment reagent at least comprises a hemolytic agent for treating and lysing erythrocytes in the sample to be detected and a first fluorescent dye for staining the cells to be detected in the sample to be detected.

Step 402, making particles in a sample liquid to be tested pass through a detection area of an optical detection system one by one, and irradiating the particles passing through the detection area with light having a first wavelength and light having a second wavelength shorter than the first wavelength.

In an embodiment of the present application, the first wavelength may be greater than 600nm, and the second wavelength may be less than or equal to 600nm. Further, the first wavelength may be 635nm; and/or the second wavelength may be 375nm, 405nm, 450nm, 488nm or 520nm.

Step 403, obtaining first optical information generated after the particles in the sample liquid to be tested are irradiated by the light with the first wavelength and second optical information generated after the particles in the sample liquid to be tested are irradiated by the light with the second wavelength.

In the embodiment of the present application, the first optical information may include first scattered light intensity information and first fluorescence intensity information generated by the first wavelength irradiating the particles in the sample liquid to be measured, and the second optical information may include second scattered light intensity information generated by the second wavelength irradiating the particles in the sample liquid to be measured.

And step 404, analyzing the cells to be detected in the sample liquid to be detected according to at least one of the scattered light intensity information in the first optical information and the second optical information and the first fluorescence intensity information in the first optical information.

In the embodiment of the application, the first fluorescence intensity information is used when analyzing the cells to be detected in the sample liquid to be detected, and if two-dimensional scatter diagram analysis is performed on the cells to be detected in the sample liquid to be detected, the corresponding other one-dimensional optical information can be any one of the following: first forward scattered light intensity information, first side scattered light intensity information, second forward scattered light intensity information; if the three-dimensional scatter diagram analysis is performed on the cells to be detected in the sample solution to be detected, the corresponding other two-dimensional optical information may be any two of the following: first forward scattered light intensity information, first side scattered light intensity information, second forward scattered light intensity information.

And step 405, identifying whether a pathogen to be detected exists in the sample liquid to be detected according to at least the second scattered light intensity information.

Preferably, the second forward scattered light intensity information in the second scattered light intensity information is used for identifying whether the pathogen to be detected exists in the sample liquid to be detected. If two-dimensional scatter diagram analysis is adopted to identify whether the pathogen to be detected exists in the sample liquid to be detected, the corresponding other one-dimensional optical information can be any one of the following: first fluorescence intensity information, first forward scattered light intensity information, first side scattered light intensity information, second side scattered light intensity information; if the three-dimensional scatter diagram analysis is adopted to identify whether the pathogen to be detected exists in the sample liquid to be detected, the corresponding other two-dimensional optical information can be any two of the following: first fluorescence intensity information, first forward scattered light intensity information, first side scattered light intensity information, second side scattered light intensity information.

In other embodiments of the present application, step 404 may be implemented by step c 11:

And c11, analyzing cells to be detected in the sample liquid to be detected according to at least one of the first forward scattering light intensity information and the first side scattering light intensity information and the first fluorescence intensity information.

In other embodiments of the present application, step 404 may also be implemented by step c 12:

And c12, analyzing cells to be detected in the sample liquid to be detected according to the second side scattering light intensity information and the first fluorescence intensity information.

In other embodiments of the present application, step 405 may be implemented by step d 11:

and d11, identifying whether a pathogen to be detected exists in the sample liquid to be detected or not according to the second forward scattering light intensity information and the second side scattering light intensity information.

It should be noted that, for further embodiments of the sample analysis method according to the fourth aspect of the present application, reference may be made to the descriptions of the respective embodiments of the sample analyzer according to the first aspect and the second aspect of the present application and the respective embodiments of the sample analysis method according to the third aspect of the present application, which are not repeated herein.

According to the sample analysis method provided by the embodiment of the application, at least two kinds of light with different wavelengths are adopted to irradiate particles in the sample liquid to be detected after the mixed treatment of the reagents, at least one of the first optical information and the second optical information obtained after the detected light with the two different wavelengths irradiates the particles and the first fluorescence intensity information in the first optical information are adopted to analyze cells to be detected in the sample liquid to be detected, and at least one other of the first optical information and the second optical information is adopted to identify whether pathogens to be detected exist in the sample liquid to be detected or not, so that the simultaneous detection of blood cells and pathogens in the sample cannot be detected simultaneously through the same sample liquid to be detected at present is realized, and the screening capability of the flow sample analyzer is improved.

The embodiment of the present application further provides a sample analysis device, and fig. 12 is a schematic structural diagram of a sample analysis device 6 provided in the embodiment of the present application, where the sample analysis device 6 includes at least one processor 61 and a memory 62, and the memory 62 stores instructions executable by the at least one processor 61, where the instructions when executed by the at least one processor 61 perform some or all of the steps of the sample analysis method described above.

The sample analysis device 6 may further comprise at least one network interface 64 and a user interface 63. The various components in the sample analysis device 6 are coupled together by a bus system 65. It is understood that the bus system 65 is used to enable connected communications between these components. The bus system 65 includes a power bus, a control bus, and a status signal bus in addition to the data bus. But for clarity of illustration the various buses are labeled as bus system 65 in fig. 12.

The user interface 63 may include, among other things, a display, keyboard, mouse, trackball, click wheel, keys, buttons, touch pad, or touch screen, etc.

It will be appreciated that the memory 62 may be volatile memory or nonvolatile memory, and may include both volatile and nonvolatile memory. The non-volatile Memory may be, among other things, a Read Only Memory (ROM), a programmable Read Only Memory (PROM, programmable Read-Only Memory), erasable programmable Read-Only Memory (EPROM, erasable Programmable Read-Only Memory), electrically erasable programmable Read-Only Memory (EEPROM, ELECTRICALLY ERASABLE PROGRAMMABLE READ-Only Memory), Magnetic random access Memory (FRAM, ferromagnetic random access Memory), flash Memory (Flash Memory), magnetic surface Memory, optical disk, or compact disk-Only (CD-ROM, compact Disc Read-Only Memory); The magnetic surface memory may be a disk memory or a tape memory. The volatile memory may be random access memory (RAM, random Access Memory) which acts as external cache memory. by way of example and not limitation, many forms of RAM are available, such as static random access memory (SRAM, static Random Access Memory), synchronous static random access memory (SSRAM, synchronous Static Random Access Memory), dynamic random access memory (DRAM, dynamic Random Access Memory), synchronous dynamic random access memory (SDRAM, synchronous Dynamic Random Access Memory), and, Double data rate synchronous dynamic random access memory (DDRSDRAM, double Data Rate Synchronous Dynamic Random Access Memory), enhanced synchronous dynamic random access memory (ESDRAM, enhanced Synchronous Dynamic Random Access Memory), synchronous link dynamic random access memory (SLDRAM, syncLink Dynamic Random Access Memory), direct memory bus random access memory (DRRAM, direct Rambus Random Access Memory). the memory 62 described in the embodiments of the present application is intended to comprise these and any other suitable types of memory.

Memory 62 includes, but is not limited to: the ternary content addressable memory, static random access memory, can store a variety of types of data, such as received sensor signals, to support operation of the sample analysis device 6.

The Processor 61 may be a central processing unit (Central Processing Unit, CPU), but may also be other general purpose Processor(s), digital signal Processor (DIGITAL SIGNAL Processor, DSP), application SPECIFIC INTEGRATED Circuit (ASIC), off-the-shelf Programmable gate array (Field-Programmable GATE ARRAY, FPGA) or other Programmable logic device, discrete gate or transistor logic device, discrete hardware components, etc. a general purpose Processor may be a microprocessor or the Processor may also be any conventional Processor, etc.

In addition, the embodiment of the application also provides a computer readable storage medium. The computer readable storage medium has stored thereon executable instructions which when executed by the processor 61 implement the steps of the sample analysis method described above. The computer readable storage medium may be the aforementioned memory or a component thereof, in which a computer program is stored and executed by the processor 61 to perform the aforementioned method steps. The computer readable storage medium may be FRAM, ROM, PROM, EPROM, EEPROM, flash Memory, magnetic surface Memory, optical disk or CD-ROM, etc., or may be a variety of devices including one or any combination of the above storage media.

It should be understood that the features, structures and advantages mentioned in the description, in the claims and in the drawings may be combined with one another at will as far as they are interesting within the scope of the application. The features, structures and advantages described for the sample analyzer of the embodiments of the present application apply in a corresponding manner to the sample analysis method, the sample analysis device and the computer-readable storage medium of the embodiments of the present application, and vice versa.

It should be understood that, in various embodiments of the present application, the sequence numbers of the foregoing processes do not mean the order of execution, and the order of execution of the processes should be determined by the functions and internal logic thereof, and should not constitute any limitation on the implementation process of the embodiments of the present application. The foregoing embodiment numbers of the present application are merely for the purpose of description, and do not represent the advantages or disadvantages of the embodiments.

The foregoing is merely an embodiment of the present application, but the protection scope of the present application is not limited thereto, and any person skilled in the art can easily think about changes or substitutions within the technical scope of the present application, and the changes and substitutions are intended to be covered in the protection scope of the present application. Therefore, the protection scope of the application is subject to the protection scope of the claims.

Claims

1. A method of sample analysis, comprising:

Mixing a sample to be detected with a treatment reagent, and reacting to obtain a sample liquid to be detected, wherein the treatment reagent at least comprises a hemolysis agent for treating red blood cells or cell membranes of the red blood cells in the sample to be detected, a first fluorescent dye for staining the cells in the sample to be detected and a second fluorescent dye for staining pathogens to be detected in the sample to be detected;

Passing particles in the sample liquid to be tested one by one through a detection zone of an optical detection system and irradiating the particles passing through the detection zone with light having a first wavelength and light having a second wavelength different from the first wavelength;

Analyzing cells to be detected in the sample liquid to be detected and identifying whether pathogens to be detected exist in the sample liquid to be detected according to different combinations of the light intensity information in the first optical information and/or the light intensity information in the second optical information.

2. The sample analysis method according to claim 1, wherein the analyzing the cells to be detected in the sample liquid to be detected and identifying whether the pathogens to be detected exist in the sample liquid to be detected based on different combinations of the respective light intensity information in the first optical information and/or the respective light intensity information in the second optical information includes:

And identifying whether a pathogen to be detected exists in the sample liquid to be detected according to at least one scattered light intensity information in the second optical information.

3. The sample analysis method according to claim 1, wherein the analyzing the cells to be detected in the sample liquid to be detected and identifying whether the pathogens to be detected exist in the sample liquid to be detected based on different combinations of the respective light intensity information in the first optical information and/or the respective light intensity information in the second optical information includes:

4. The sample analysis method according to claim 1, wherein the analyzing the cells to be detected in the sample liquid to be detected and identifying whether the pathogens to be detected exist in the sample liquid to be detected based on different combinations of the respective light intensity information in the first optical information and/or the respective light intensity information in the second optical information includes:

And identifying whether a pathogen to be detected exists in the sample liquid to be detected according to at least one of the first optical information and the second fluorescence intensity information in the second optical information.

5. The sample analysis method according to claim 1, wherein the analyzing the cells to be detected in the sample liquid to be detected and identifying whether the pathogens to be detected exist in the sample liquid to be detected based on different combinations of the respective light intensity information in the first optical information and/or the respective light intensity information in the second optical information includes:

Analyzing cells to be detected in the sample liquid to be detected according to at least one piece of scattered light intensity information in the first optical information and first fluorescence intensity information in the first optical information;

and identifying whether a pathogen to be detected exists in the sample liquid to be detected according to at least one piece of scattered light intensity information in the second optical information and the second fluorescence intensity information in the second optical information.

6. The sample analysis method of any of claims 2-5, wherein the scattered light intensity information comprises side scattered light intensity information.

7. The method for analyzing a sample according to any one of claims 1 to 5, wherein,

The cells to be detected are white blood cells and/or the pathogen to be detected is a parasite.

8. The method for analyzing a sample according to any one of claims 1 to 5, wherein,

The cells to be detected are nucleated erythrocytes and/or the pathogen to be detected is a parasite.

9. A sample analyzer, the sample analyzer comprising:

An optical detection system comprising a first light source for irradiating particles flowing in a flow chamber with light having a first wavelength so as to generate first optical information, a second light source for irradiating particles flowing in the flow chamber with light having a second wavelength different from the first wavelength so as to generate second optical information, a flow chamber in which particles in the sample liquid to be detected can flow, a first detector for collecting the first optical information, and a second detector for collecting the second optical information;

A processor configured to obtain the first optical information and the second optical information from the optical detection system; analyzing cells to be detected in the sample liquid to be detected and identifying whether pathogens to be detected exist in the sample liquid to be detected according to different combinations of the light intensity information in the first optical information and/or the light intensity information in the second optical information.

10. The sample analyzer of claim 9, wherein said analyzing cells to be detected in the test sample fluid and identifying the presence or absence of pathogens to be detected in the test sample fluid based on different combinations of light intensity information in the first optical information and/or light intensity information in the second optical information comprises:

11. The sample analyzer of claim 9, wherein said analyzing cells to be detected in the test sample fluid and identifying the presence or absence of pathogens to be detected in the test sample fluid based on different combinations of light intensity information in the first optical information and/or light intensity information in the second optical information comprises:

12. The sample analyzer of claim 9, wherein said analyzing cells to be detected in the test sample fluid and identifying the presence or absence of pathogens to be detected in the test sample fluid based on different combinations of light intensity information in the first optical information and/or light intensity information in the second optical information comprises:

13. The sample analyzer of claim 9, wherein said analyzing cells to be detected in the test sample fluid and identifying the presence or absence of pathogens to be detected in the test sample fluid based on different combinations of light intensity information in the first optical information and/or light intensity information in the second optical information comprises:

14. The sample analyzer of any of claims 10-13, wherein the scattered light intensity information comprises side scattered light intensity information.

15. The sample analyzer according to any of claims 9-13, wherein,

16. The sample analyzer according to any of claims 9-13, wherein,